Skip to search.
 FTSE 100 Up 3.56%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
20.35 Up 0.17(0.84%) 16:53
Add to Portfolio
Prev Close:20.18
Open:20.20
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.14557
Next Earnings Date:N/A
Day's Range:20.35 - 20.70
52wk Range:19.60 - 24.90
Volume:1,775
Avg Vol (3m):36,186
Market Cap:98.37b
P/E (ttm):6.49
EPS (ttm):3.14
Div & Yield:1.19 (5.94%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.24
P/S (ttm):2.65
Ex-Dividend Date:13-Aug-15

Analysts

Annual EPS Est (Dec-15) :74.95
Quarterly EPS Est (Sep-15) :19.96
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):2.82

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback